The human epidermal growth factor receptor 2 (HER2/neu) is a transmembrane glycoprotein, where the presence of HER2 overexpression appears to be a key factor in malignant transformation and is predictive of a poor prognosis in breast cancer. This evidence concerns the gene ERBB2 and breast cancer.